Jasper Therapeutics - JSPR Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of jaspertherapeutics.com (JSPR)

Thanks to patent protection, Jasper Therapeutics (JSPR) has created a significant barrier for competitors in transplantation preparation. After analyzing the year-over-year product sales dynamics for the TTM on GURU.Markets, we find that 0.00 captures the current value of the indicator. The company's prospects rely on the development of autoimmune pathology therapies and strong pricing power derived from its safe bone marrow cleansing method.

Jasper Therapeutics, Inc. (JSPR): Sales Growth YoY (TTM) from 02/11/2024 to 11/18/2026

Jasper Therapeutics, Inc. (JSPR) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:Jasper Therapeutics Inc
Flagship merchandise of jaspertherapeutics.com

Institutional capital evaluates Jasper Therapeutics (JSPR) through the lens of revenue scalability. This TTM sales volume change indicator calculates the rolling daily revenue growth rate over the year, neutralizing random market fluctuations. The metric reveals hidden systemic risks that require hedging at extreme values. For a biotech company developing alliances with Big Pharma, this indicator confirms the effectiveness of organic growth. The stability of the curve determines the fundamental reliability of the asset.